[en] The neuroendocrine control of reproduction in mammals is governed by a neural hypothalamic network of nearly 1500 gonadotropin-releasing hormone (GnRH) secreting neurons that modulate the activity of the reproductive axis across life. Congenital hypogonadotropic hypogonadism (HH) is a clinical syndrome that is characterized by partial or complete pubertal failure. HH may result from inadequate hypothalamic GnRH axis activation, or a failure of pituitary gonadotropin secretion/effects. In man, several genes that participate in olfactory and GnRH neuronal migration are thought to interact during the embryonic life. A growing number of mutations in different genes are responsible for congenital HH. Based on the presence or absence of olfaction dysfunction, HH is divided in two syndromes: HH with olfactory alterations [Kallmann syndrome (KS)] and idiopathic hypogonadotropic hypogonadism (IHH) with normal smell (normosmic IHH). KS is a heterogeneous disorder affecting 1 in 5000 males, with a three to fivefold of males over females. KS is associated with mutations in KAL1, FGFR1/FGF8, FGF17, IL17RD, PROK2/PROKR2, NELF, CHD7, HS6ST1, FLRT3, SPRY4, DUSP6, SEMA3A, NELF, and WDR11 genes that are related to defects in neuronal migration. These reproductive and olfactory deficits include a variable non-reproductive phenotype, including sensorineural deafness, coloboma, bimanual synkinesis, craniofacial abnormalities, and/or renal agenesis. Interestingly, defects in PROKR2, FGFR1, FGF8, CHD7, DUSP6, and WDR11 genes are also associated with normosmic IHH, whereas mutations in KISS1/KISSR, TAC3/TACR3, GNRH1/GNRHR, LEP/LEPR, HESX1, FSHB, and LHB are only present in patients with normosmic IHH. In this paper, we summarize the reproductive, neurodevelopmental, and genetic aspects of HH in human pathology.
Debray, François-Guillaume ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Maladies métaboliques d'origine génétique
Bours, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Language :
English
Title :
Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes.
Valdes-Socin, S., Debray, F.G., Parent, A.S., Lebrethon, M.C., Bourguignon, J.P., Bours, V., How to explorcongenital isolated hypogonadotropic hypogonadism? (2010) Rev Med Liege, 65 (11), pp. 634-641
Semple, R., Topaloglu, K.A., The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions (2010) Clin Endocrinol, 72 (4), pp. 427-435. , doi: (Oxf) 10.1111/j.1365-2265.2009.03687.x
Nachtigall, L.B., Boepple, P.A., Pralong, F.P., Crowley, W.F., Adult-onset idiopathic hypogonadotropic hypogonadism - a treatable form of male infertility (1997) N Engl J Med, 336, pp. 410-415. , doi:10.1056/NEJM199702063360604
Lippincott, M.F., True, C., Seminara, S.B., Use of genetic models of idiopathic hypogonadotrophic hypogonadism in mice and men to understand the mechanisms of disease (2013) Exp Physiol, 98, pp. 1522-1527. , doi:10.1113/expphysiol.2013.071910
Valdes-Socin, H., Salvi, R., Thiry, A., Daly, A.F., Pralong, F.P., Gaillard, R., Testicular effects of isolated luteinizing hormone deficiency and reversal by long-term human chorionic gonadotropin treatment (2009) J Clin Endocrinol Metab, 94, pp. 3-4. , doi:10.1210/jc.2008-1584
Trarbach, E.B., Costa, E.M., Versiani, B., de Castro, M., Matias Baptista, M.T., Mendes Garmes, H., Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia (2006) J Clin Endocrinol Metab, 91, pp. 4006-4012. , doi:10.1210/jc.2005-2793
Pitteloud, N., Acierno, J.S., Meysing, A., Eliseenkova, A.V., Ma, J., Ibrahimi, O.A., Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism (2006) Proc Natl Acad Sci, 103, pp. 6281-6286. , doi:10.1073/pnas.0600962103U S A
Pitteloud, N., Hayes, F.J., Boepple, P.A., DeCruz, S., Seminara, S.B., MacLaughlin, D.T., The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism (2002) J Clin Endocrinol Metab, 87, pp. 152-160. , doi:10.1210/jcem.87.1.8131
Sykiotis, G.P., Plummer, L., Hughes, V.A., Au, M., Durrani, S., Nayak-Young, S., Oligogenic basis of isolated gonadotropin-releasing hormone deficiency (2010) Proc Natl Acad Sci U S A, 107, pp. 15140-15144. , doi:10.1073/pnas.1009622107
Fukami, M., Maruyama, T., Dateki, S., Sato, N., Yoshimura, Y., Ogata, T., Hypothalamic dysfunction in a female with isolated hypogonadotropic hypogonadism and compound heterozygous TACR3 mutations and clinical manifestation in her heterozygous mother (2010) Horm Res Paediatr, 73, pp. 477-481. , doi:10.1159/000313373
Raivio, J., Falardeau, A., Dwyer, R., Quinton, F.J., Hayes, V.A., Hughes, L.W., Reversal of idiopathic hypogonadotropic hypogonadism (2007) N Engl J Med, 357, pp. 863-873. , doi:10.1056/NEJMoa066494
Pitteloud, N., Acierno, J.S., Meysing, A.U., Dwyer, A.A., Hayes, F.J., Crowley, W.F., Reversible Kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene (2005) J Clin Endocrinol Metab, 90, pp. 1317-1322. , doi:10.1210/jc.2004-1361
Gianetti, E., Tusset, C., Noel, S.D., Au, M.G., Dwyer, A.A., Hughes, V.A., TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood (2010) J Clin Endocrinol Metab, 95, pp. 2857-2867. , doi:10.1210/jc.2009-2320
Laitinen, E.M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., Raivio, T., Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations (2012) PLoS One, 7, pp. e39450. , doi:10.1371/journal.pone.0039450
Cariboni, A., Maggi, R., Kallmann's syndrome, a neuronal migration defect (2006) Cell Mol Life Sci, 63 (21), pp. 2512-2526. , doi:10.1007/s00018-005-5604-3
Bouligand, J., Ghervan, C., Tello, J.A., Brailly-Tabard, S., Salenave, S., Chanson, P., Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation (2009) N Engl J Med, 360, pp. 2742-2748. , doi:10.1056/NEJMoa0900136
Chan, Y.M., de Guillebon, A., Lang-Muritano, M., Plummer, L., Cerrato, F., Tsiaras, S., GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism (2009) Proc Natl Acad Sci, 106, pp. 11703-11708. , U S Adoi:10.1073/pnas.0903449106
de Roux, N., Genin, E., Carel, J.C., Matsuda, F., Chaussain, J.L., Milgrom, E., Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 (2003) Proc Natl Acad Sci, 100, pp. 10972-10976. , U S Adoi:10.1073/pnas.1834399100
Topaloglu, A.K., Tello, J.A., Kotan, L.D., Ozbek, M.N., Yilmaz, M.B., Erdogan, S., Inactivating KISS1 mutation and hypogonadotropic hypogonadism (2012) N Engl J Med, 366, pp. 629-635. , doi:10.1056/NEJMoa1111184
Brioude, F., Bouligand, J., Francou, B., Fagart, J., Roussel, R., Viengchareun, S., Two families with normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R (KISS1 receptor): clinical evaluation and molecular characterization of a novel mutation (2013) PLoS One, 8 (1), pp. e53896. , doi:10.1371/journal.pone.0053896
Tenenbaum-Rakover, Y., Commenges-Ducos, M., Iovane, A., Aumas, C., Admoni, O., de Roux, N., Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54 (2007) J Clin Endocrinol Metab, 92, pp. 1137-1144. , doi:10.1210/jc.2006-2147
Valdes-Socin, H., Cavalier, E., Beckaert, A., Carlisi, A., Chavez, M., Beckers, A., High plasma kisspeptins in obese men with acquired hypogonadism and in men with congenital hypogonadism: pilot study of plasma kisspeptins variations before and after hCG and testosterone administration (2011) Ann Endocrinol (Paris)
Valdes-Socin, H., Munaut, C., Chavez, M., Chantrain, F., Delbecque, K., Delvenne, P., Expression and spatio-temporal distribution of KISS1 and its receptor KISSR in human normal and pathological placentae (2012) Ann Endocrinol, 4, p. 374. , (Paris)doi:10.1016/j.ando.2012.07.494
Topaloglu, A.K., Reimann, F., Guclu, M., Yalin, A.S., Kotan, D., Porter, K.M., TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction (2009) Nat Genet, 41, pp. 354-358. , doi:10.1038/ng.306
Guran, T., Tolhurst, G., Bereket, A., Rocha, N., Porter, K., Turan, S., A novel missense mutation in the first extracellular loop of the neurokinin B receptor causes hypogonadotropic hypogonadism (2009) J Clin Endocrinol Metab, 94, pp. 3633-3639. , doi:10.1210/jc.2009-0551
Francou, B., Bouligand, J., Voican, A., Amazit, L., Trabado, S., Fagart, J., Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations (2011) PLoS One, 6, pp. e25614. , doi:10.1371/journal.pone.0025614
Farooqi, I.S., Wangensteen, T., Collins, S., Kimber, W., Matarese, G., Keogh, J.M., Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor (2007) N Engl J Med, 356, pp. 237-247. , doi:10.1056/NEJMoa063988
Pasqualini, R.Q., Bur, G.E., Síndrome hipoandrogénico con gametogénesis conservada: clasificación de la insuficiencia testicular (1950) Rev Asoc Med Argent, 64, pp. 15-30
Weiss, J., Axelrod, L., Whitcomb, R.W., Harris, P.E., Crowley, W.F., Jameson, J.L., Hypogonadism caused by a single amino acid substitution in the subunit of luteinizing hormone (1992) N Engl J Med, 326, pp. 179-183. , doi:10.1056/NEJM199201163260306
Valdes-Socin, H., Salvi, R., Daly, A.F., Gaillard, R.C., Quatresooz, P., Tebeu, P.-M., Hypogonadism in a patient with a mutation in the luteinizing hormone-subunit gene (2004) N Engl J Med, 351, pp. 2619-2625. , doi:10.1056/NEJMoa040326
Lofrano-Porto, A., Barra, G.B., Giacomini, L.A., Nascimento, P.P., Latronico, A.C., Casulari, L.A., Luteinizing hormone mutation and hypogonadism in men and women (2007) N Engl J Med, 357, pp. 897-904. , doi:10.1056/NEJMoa071999
Achard, C., Courtillot, C., Lahuna, O., Me'duri, G., Soufir, J.C., Lie're, P., Normal spermatogenesis in a man with mutant luteinizing hormone (2009) N Engl J Med, 361, pp. 1856-1863. , doi:10.1056/NEJMoa0805792
Basciani, S., Watanabe, M., Mariani, S., Passeri, M., Persichetti, A., Fiore, D., Hypogonadism in a patient with two novel mutations of the luteinizing hormone -subunit gene expressed in a compound heterozygous form (2012) J Clin Endocrinol Metab, 97, pp. 3031-3038. , doi:10.1210/jc.2012-1986
Daly, A., Valdes-Socin, H., Beckers, A., A tall man with hypogonadism. In: Wartofsky L, editor. Diagnostic Dilemmas: Images in Endocrinology (2011), pp. 204-207. , Washington DC:The Endocrine Society Press
Legouis, R., Hardelin, J.P., Levilliers, J., Claverie, J.M., Compain, S., Wunderle, V., The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules (1991) Cell, 67, pp. 423-435. , doi:10. 1016/0092-8674(91)
Sato, N., Katsumata, N., Kagami, M., Hasegawa, T., Hori, N., Kawakita, S., Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGR1, or KAL2) in five families and 18 sporadic patients (2004) J Clin Endocrinol Metab, 89. , doi:10.1210/jc.2003-030476
Tsai, P.S., Gill, J.C., Mechanisms of disease: insights into X-linked and autosomal-dominant Kallmann syndrome (2006) Nat Clin Pract Endocrinol Metab, 2, pp. 160-171. , doi:10.1038/ncpendmet0119
Dodé, C., Levilliers, J., Dupont, J.M., De Paepe, A., Le Dû, N., Soussi-Yanicostas, N., Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome (2003) Nat Genet, 33, pp. 463-465. , doi:10.1038/ng1122
Dodé, C., Teixeira, L., Levilliers, J., Fouveaut, C., Bouchard, P., Kottler, M.L., Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2 (2006) PLoS Genet, 2 (10), pp. e175. , doi:10.1371/journal.pgen.0020175
Miraoui, H., Dwyer, A.A., Sykiotis, G.P., Plummer, L., Chung, W., Feng, B., Mutations in FGF17, IL17RD, DUPS6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism (2013) Am J Hum Genet, 92, pp. 725-743. , doi:10.1016/j.ajhg.2013.04.008
Cole, L.W., Sidis, Y., Zhang, C.K., Quinton, R., Plummer, L., Pignatelli, D., Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin releasing hormone deficiency: molecular genetics and clinical spectrum (2008) J Clin Endocrinol Metab, 93, pp. 3551-3559. , doi:10.1210/jc.2007-2654
Matsumoto, S., Yamazaki, C., Masumoto, K., Nagano, M., Naito, M., Soga, T., Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2 (2006) Proc Natl Acad Sci U S A, 103, pp. 4140-4145. , doi:10.1073/pnas.0508881103
McCabe, M.J., Gaston-Massuet, C., Gregory, L.C., Alatzoglou, K.S., Tziaferi, V., Sbai, O., Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia (2013) J Clin Endocrinol Metab, 98, pp. 547-557. , doi:10.1210/jc.2012-3067
Kramer, P.R., Wray, S., Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons (2000) Genes Dev, 14, pp. 1824-1834
Kim, H.G., Ahn, J.W., Kurth, I., Ullmann, R., Kim, H.T., Kulharya, A., WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome (2010) Am J Hum Genet, 87 (4), pp. 465-479. , doi:10.1016/j.ajhg.2010.08.018
Kim, H.G., Kurth, I., Lan, F., Meliciani, I., Wenzel, W., Eom, S.H., Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome (2008) Am J Hum Genet, 83, pp. 511-519. , doi:10.1016/j.ajhg.2008.09.005
Bergman, J.E., de Ronde, W., Jongmans, M.C., Wolffenbuttel, B.H., Drop, S.L., Hermus, A., The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome (2012) J Clin Endocrinol Metab, 97 (5), pp. E858-E862. , doi:10.1210/jc.2011-2652
Tornberg, J., Sykiotis, G.P., Keefe, K., Plummer, L., Hoang, X., Hall, J.E., Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism (2011) Proc Natl Acad Sci, 108, pp. 11524-11529. , U S Adoi:10.1073/pnas.1102284108
McNay, D.E., Turton, J.P., Kelberman, D., Woods, K.S., Brauner, R., Papadimitriou, A., HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism (2007) J Clin Endocrinol Metab, 92, pp. 691-697. , doi:10.1210/jc.2006-1609
Newbern, K., Natrajan, N., Kim, H.-G., Chorich, L.P., Halvorson, L.M., Cameron, R.S., Identification of HESX1 mutations in Kallmann syndrome (2013) Fertil Steril, 99, pp. 1831-1837. , doi:10.1016/j.fertnstert.2013.01.149
Young, J., Metay, C., Bouligand, J., Tou, B., Francou, B., Maione, L., SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development (2012) Hum Reprod, 27, pp. 1460-1465. , doi:10.1093/humrep/des022
